|
(Health-NewsWire.Net, October 22, 2021 )
Market Overview
Breast cancer screening is carried out to detect cancer in its early stages and ensure timely treatment to the patients. Early diagnosis is a key to a successful breast cancer treatment.
Breast cancer can be diagnosed early by screening tests like yearly mammograms, CT scans, and MRI. Once the symptoms are visually detectable, an individual is advised to undergo a diagnostic test to confirm the suspects of breast cancer.
View full report: https://bit.ly/30UbX3D
Market Dynamics
The breast cancer screening and diagnostic techniques market growth is driven by the rising prevalence of breast cancer coupled with the emergence of novel therapies, increasing awareness about the early detection of breast cancer, and increasing government initiatives and support.
Early detection of cancer also helps in increasing the survival rate, better life quality, and improved treatment options. Moreover, increased intensive research and development in the field of cancer, technological advancements are key factors to drive the growth of the market.
The rising prevalence of breast cancer coupled with the rise in the emergence of new technologies in early screening and diagnosis, is expected to drive the global breast cancer screening and diagnostic techniques market growth
The incidence of breast cancers is proliferating. According to the World Health Organization (WHO) scenario, breast cancer is the second most cancer occurring among women. It affects nearly 2.1 million women each year. According to the American Cancer Society, around 281,550 women are projected to be diagnosed with breast cancer in 2021, and 43,600 women are predicted to die from breast cancer in the US.
According to Cancer Treatment Centers of America, women above 60 years of age are more likely to be diagnosed and only about 10% to 15% of cases occur in women younger than 45 years of age.
In addition, the rise in the emergence of new technologies in early screening and diagnosis for breast cancer is also driving the growth of the breast cancer diagnostics market globally. For instance, on July 10th, 2019, Arizona-based SimonMed Imaging announced its implementation of the first U.S. Food and Drug Administration (FDA)-cleared artificial intelligence (AI) program for significantly enhancing early breast cancer detection for 3-D mammography. The AI program, called ProFound AI for digital breast tomosynthesis (DBT), was developed by iCAD Inc.
Market Segmentation:
By Cancer Type
HER2-enriched
Luminal A
Luminal B
Triple-negative/basal-like
By Screening and Diagnostic Type
Clinical Breast Exam
Breast Imaging Modalities
Biopsy
By End-user
Hospitals & Clinics
Cancer Centers
Ambulatory Surgical Centers
Download free sample: https://bit.ly/3nnPcN4
Geographical Analysis
North America region holds the largest market share of global breast cancer screening and diagnostic techniques market
North America dominates the breast cancer screening and diagnostics market due to rising breast cancer cases and increasing technological advancements for cancer diagnosis. For instance, about 1 in 8 U.S. women (about 12%) will develop invasive breast cancer over the course of their lifetime.
In 2019, an estimated 268,600 new cases of invasive breast cancer were expected to be diagnosed in women in the U.S., along with 62,930 new cases of non-invasive (in situ) breast cancer. About 2,670 new cases of invasive breast cancer are expected to be diagnosed in men in 2019. A man's lifetime risk of breast cancer is about 1 in 883.
In addition, increasing initiatives taken by the manufacturers to create awareness about breast cancer are driving the market's growth in this region. For instance, in July 2019, Fujifilm Medical Systems USA has launched a nationwide effort to enhance access to breast cancer screening and raise awareness about the importance of early disease detection. Called "Aspire to Be Fearless," the 18-month, 48-state campaign features a mobile mammography bus that will travel around the country to educate local communities and offer mammograms.
New product developments, acquisitions, collaborations, and regional expansions are some of the key strategic initiatives major players undertake to maintain stability in the market. For instance, In July 2019, Exact Sciences Corp and Genomic Health Inc. entered into a definitive agreement in which these companies will create a leading global cancer diagnostics company. The combined company will offer two of the strongest and fastest-growing brands in cancer diagnostics, Cologuard and Oncotype DX.
Competitive Landscape
The global breast cancer screening and diagnostic techniques market is highly competitive with the presence of global companies. Some of the key players which are contributing to the growth of the market include Allengers, Myriad Genetics, Inc, Siemens Healthcare GmbH, GE Healthcare, Hologic Inc, Abbott Laboratories, QIAGEN, Paragon Biosciences LLC, Quest Diagnostics Incorporated.
The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market globally. For instance, In July 2019, Paragon Biosciences launched the seventh portfolio company, Qlarity Imaging LLC, which was founded to harness the value of artificial intelligence (AI) to improve medical outcomes.
Topic's you may be interested, Ultrasound Simulation Market, Bone Cancer Diagnosis Market, In-vitro Cancer Diagnostics Market, Mammography Detectors Market, Contrast Media Injectors Market
DataM Intelligence
Sai Kiran
+1 877 441 4866
pr@datamintelligence.com
Source: EmailWire.Com 
|
